Management and outcomes of ventricular septal defects after acute myocardial infarction: A multicenter retrospective study.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 09 03 2022
accepted: 29 10 2022
pubmed: 16 11 2022
medline: 6 1 2023
entrez: 15 11 2022
Statut: ppublish

Résumé

The mortality rate of patients with post-myocardial infarction (MI) ventricular septal defects (VSDs) is high, and the benefit of surgery is unclear. We aimed to investigate the management and outcomes of post-MI VSD over a 10-year period in a large cohort. Data of patients with post-MI VSD admitted in three French university hospitals from 2008 to 2019 were examined. The characteristics of those who underwent surgery were compared with those who received medical treatment. Mortality risk factors, survival curves, and outcomes at 30 days and 1 year after treatment were determined. Of the 92 patients whose data were examined, 50 underwent surgery and 42 received exclusive medical treatment. All patients were critically ill. Overall, 76.1% of patients received inotropic support, and 63% received mechanical ventilation. Circulatory assistance, mainly via intra-aortic balloon pump and extra-corporeal membrane oxygenation, was provided to 46.7% patients, with 14.1% requiring a second assistance. The median time to surgery was 4 days. At 1 year, mortality was 46% in those who underwent surgery and 83.3% in those treated medically (p < .001). Survival curves at 1 and 3 months showed major differences, and the survival rate showed little change 30 days after treatment. Cardiogenic shock and cardiac arrest emerged as risk factors for mortality. In our retrospective, multicenter study, the mortality resulting from post-MI VSD did not seem to improve over the last decade. Although surgery carried considerable risks, it improved survival.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
The mortality rate of patients with post-myocardial infarction (MI) ventricular septal defects (VSDs) is high, and the benefit of surgery is unclear. We aimed to investigate the management and outcomes of post-MI VSD over a 10-year period in a large cohort.
METHODS METHODS
Data of patients with post-MI VSD admitted in three French university hospitals from 2008 to 2019 were examined. The characteristics of those who underwent surgery were compared with those who received medical treatment. Mortality risk factors, survival curves, and outcomes at 30 days and 1 year after treatment were determined.
RESULTS RESULTS
Of the 92 patients whose data were examined, 50 underwent surgery and 42 received exclusive medical treatment. All patients were critically ill. Overall, 76.1% of patients received inotropic support, and 63% received mechanical ventilation. Circulatory assistance, mainly via intra-aortic balloon pump and extra-corporeal membrane oxygenation, was provided to 46.7% patients, with 14.1% requiring a second assistance. The median time to surgery was 4 days. At 1 year, mortality was 46% in those who underwent surgery and 83.3% in those treated medically (p < .001). Survival curves at 1 and 3 months showed major differences, and the survival rate showed little change 30 days after treatment. Cardiogenic shock and cardiac arrest emerged as risk factors for mortality.
CONCLUSIONS CONCLUSIONS
In our retrospective, multicenter study, the mortality resulting from post-MI VSD did not seem to improve over the last decade. Although surgery carried considerable risks, it improved survival.

Identifiants

pubmed: 36378912
doi: 10.1111/jocs.17151
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5019-5026

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ. Ventricular septal rupture after acute myocardial infarction. N Engl J Med. 2002;347:1426-1432.
Gueret P, Khalife K, Jobic Y, et al. Echocardiographic assessment of the incidence of mechanical complications during the early phase of myocardial infarction in the reperfusion era: a French multicentre prospective registry. Arch Cardiovasc Dis. 2008;101:41-47.
Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation. 2000;101:27-32.
Moreyra AE, Huang MS, Wilson AC, Deng Y, Cosgrove NM, Kostis JB. Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction. Am J Cardiol. 2010;106:1095-1100.
Arnaoutakis GJ, Zhao Y, George TJ, Sciortino CM, McCarthy PM, Conte JV. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2012;94:436-444.
Sathananthan J, Ruygrok P. Evolution in the management of postinfarct ventricular septal defects from surgical to percutaneous approach: a single-center experience. J Invasive Cardiol. 2013;25:339-343.
Schlotter F, de Waha S, Eitel I, Desch S, Fuernau G, Thiele H. Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence. EuroIntervention. 2016;12:94-102.
Thiele H, Kaulfersch C, Daehnert I, et al. Immediate primary transcatheter closure of postinfarction ventricular septal defects. Eur Heart J. 2008;30:81-88.
Assenza GE, McElhinney DB, Valente AM, et al. Transcatheter closure of post-myocardial infarction ventricular septal rupture. Circ Cardiovasc Interven. 2013;6:59-67.
Rey DF, Rigamonti F, Chaara J, et al. Communication interventriculaire postinfarctus du myocarde: mise au point. Rev Med Suisse. 2017;3(564):1088-1093.
Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177.
O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:529-555.
Goyal A, Menon V. Contemporary management of post-MI ventricular septal rupture, expert analysis. Am Coll Card. 2018;. https://www.acc.org/latest-in-cardiology/articles/2018/07/30/06/58/contemporary-management-of-post-mi-ventricular-septal-rupture
Iyer S, Bauer T, Yeung M, et al. A heart team and multi-modality imaging approach to percutaneous closure of a post-myocardial infarction ventricular septal defect. Cardiovasc Diagn Ther. 2016;6:180-184.
Jones BM, Kapadia SR, Smedira NG, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J. 2014;35:2060-2068.

Auteurs

Pierre-Guillaume Piriou (PG)

Department of Cardiology, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Patrice Guerin (P)

Department of Cardiology, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Julien Plessis (J)

Department of Cardiology, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Thomas Senage (T)

Department of Thoracic and Cardio-Vascular Surgery, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Thibaut Manigold (T)

Department of Cardiology, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Vincent Auffret (V)

Department of Cardiology, CHU Rennes, Rennes, France.

Romain Didier (R)

Department of Cardiology, CHU Brest, Brest, France.

Robin Le Ruz (R)

Department of Cardiology, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Charles-Henri David (CH)

Department of Thoracic and Cardio-Vascular Surgery, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Jean-Christian Roussel (JC)

Department of Thoracic and Cardio-Vascular Surgery, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Vincent Letocart (V)

Department of Cardiology, Nantes Université, CHU Nantes, l'institut du thorax, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH